Levitt’s CO breath test in the differential diagnosis of chronic isolated hyperbilirubinemia
Ling-Ling Kang(Guangdong Medical College), Hou‐De Zhang(Anshan Hospital), Quan‐Sheng Han(Amway (United States)), Xie Xian-hui(Shenzhen Institute of Information Technology), Yongqiang Ji(Shenzhen Institute of Information Technology), Junfeng Luo(Shenzhen University), Guoliang Zhu(East China University of Science and Technology), Kunmei Ji(Shenzhen University), Zelin Liu(Guangdong Medical College), Lingwen Liu(Shenzhen Institute of Information Technology), Yongjian Ma(Shenzhen Institute of Information Technology), Yuan‐Wu Chen(Guangdong Medical College)
Cited by 4
Related Papers
A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules
|Nature Communications|2019|424
A versatile biosensing platform coupling CRISPR–Cas12a and aptamers for detection of diverse analytes
|Science Bulletin|2020|95
Activating cryptic biosynthetic gene cluster through a CRISPR–Cas12a-mediated direct cloning approach
|Nucleic Acids Research|2022|68
Human erythrocyte lifespan measured by Levitt’s CO breath test with newly developed automatic instrument
|Journal of Breath Research|2018|62
Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease
|Kidney & Blood Pressure Research|2019|54